 phase i/ii trial recombin human granulocyte-macrophag colony-stimul factor allogen bone marrow transplant forty-seven patient hematolog neoplasia recombin human granulocyte-macrophag colony-stimul factor rhgm-csf daili infus allogen bone marrow transplant hla-ident donor phase i-ii dose-escal trial dose level dose toxic rhgm-csf neglig patient unaccept side effect rhgm-csf differ graft-versus-host diseas gvhd prophylact regimen twenty-seven evalu patient regimen methotrex mtx group absolut neutrophil count median day contrast patient gvhd prophylact regimen mtx group II absolut neutrophil count median day patient group febril day initi hospit patient group II overal incid sever acut gvhd rhgm-csf-treat patient similar histor good risk patient rhgm-csf preliminari data rhgm-csf unlik gvhd hla-ident donor transplant need random trial rhgm-csf allogen marrow transplant patient